Skip to content
Review

NF2/Merlin Regulates Cell Proliferation and Cell Migration through YAP/TAZ and AMOT.

Aug 2026 · Cold Spring Harbor Perspectives in Biology · pp. a041913 · 0 citations
Medicine

TL;DR

This review summarizes recent advances in how NF2 regulates YAP/TAZ and AMOT functions, focusing on their roles in tumor formation, metastasis, and angiogenesis.

Abstract

The Hippo pathway is a central regulator of tissue homeostasis, organ growth, and tumorigenesis. NF2 (Neurofibromin 2, also known as Merlin) functions as a pivotal upstream component that integrates biochemical and mechanical cues to restrain the activity of the transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ), thereby limiting cell proliferation. In addition, NF2 regulates members of the Motin family proteins (AMOT, AMOTL1, and AMOTL2) through ubiquitin-mediated turnover to modulate YAP/TAZ signaling output. Moreover, NF2 controls AMOT proteolytic processing to reorganize the actin cytoskeleton, thereby influencing cell motility. Through these mechanisms, NF2 establishes a multilayered regulatory system that coordinates cell proliferation and cell migration. This review summarizes recent advances in how NF2 regulates YAP/TAZ and AMOT functions, focusing on their roles in tumor formation, metastasis, and angiogenesis.

View source

Similar papers

Review Aug 2026

Transcriptional Regulation by YAP/TAZ via TEADs and Additional Transcription Factors.

This review provides an updated overview of this transcriptional module within the Hippo pathway, discusses how it modulates gene transcription to contribute to development and disease, and proposes outstanding questions that warrant further investigation in future studies.

Xiao-Lei Cao, Mei Tang, Zezhen Lu et al. · 0 citations
Review Aug 2026

Transcriptional and Epigenetic Regulation of Cell Fate by YAP and TAZ.

A unified mechanistic framework by which the level of YAP/TAZ activity determines enhancer landscapes that favor either differentiated or progenitor-like cellular states is proposed, providing a potential basis for applications to regenerative medicine and therapeutic interventions.

Ju-Gyeong Kang, Taejun Seol, Younghoon Kim et al. · 0 citations
Open access Sep 2026

YAP-mediated mechanotransduction promotes hepatocellular carcinoma progression by targeting ATP1A1/CXCL1 axis.

It is demonstrated that increased matrix stiffness activates YAP/TEAD4-dependent transcriptional program and promotes ATP1A1 expression, thereby converting mechanical cues into chemical signaling output and finally promoting malignant phenotypes in the tumor.

Meng-Nan Zhang, Xin-Peng Wen, Jingyi Liu et al. · 0 citations
Aug 2026

NUAK Kinases in the Hippo Pathway.

Small-molecule NUAK inhibitors are in development, several of which have been shown to reactivate Hippo signaling, restore YAP/TAZ cytoplasmic retention, and suppress aberrant cancer cell proliferation and fibrosis.

Youchen Song, Liliana Attisano · 0 citations
Review Aug 2026

Hippo-YAP/TAZ Signaling in the Respiratory System.

The spatiotemporal control of core pathway components in murine and human lungs is reviewed, highlighting how YAP and TAZ integrate mechanical and molecular cues to govern epithelial patterning, mesenchymal function, vascular integrity, and stem cell behavior.

K. Kontodimas, X. Varelas · 0 citations
Review Sep 2026

Upstream Regulation of the Hippo Pathway.

Studies of the Hippo signaling pathway have revealed a highly complex network of interacting regulatory mechanisms that together control pathway output and tissue growth. An overriding theme of this regulation is that it functions to link basic cellular architecture and processes to pathway function, thereby allowing t...

Sherzod A. Tokamov, R. Fehon · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.